Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-03-14

Clinical Trial Update: Chemotherapy Plus Trastuzumab in Treating Patients With Breast Cancer [Phase 1]

View source ↗

Summary

The Phase 1 trial evaluating chemotherapy in combination with trastuzumab for breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HERCEPTIN (trastuzumab)

Snippet

Sponsor: Dartmouth-Hitchcock Medical Center | Conditions: Breast Cancer | Phase 1 | Status: COMPLETED